Koul HK - Search Results

1

Role of testosterone in managing advanced prostate cancer.

Rove KO, Debruyne FM, Djavan B, Gomella LG, Koul HK, Lucia MS, Petrylak DP, Shore ND, Stone NN, Crawford ED. Rove KO, et al. Among authors: koul hk. Urology. 2012 Oct;80(4):754-62. doi: 10.1016/j.urology.2012.05.006. Epub 2012 Jul 13. Urology. 2012. PMID: 22795376 Review.

2

Correlation between LUTS (AUA-SS) and erectile dysfunction (SHIM) in an age-matched racially diverse male population: data from the Prostate Cancer Awareness Week (PCAW).

Barqawi A, O'Donnell C, Kumar R, Koul H, Crawford ED. Barqawi A, et al. Int J Impot Res. 2005 Jul-Aug;17(4):370-4. doi: 10.1038/sj.ijir.3901340. Int J Impot Res. 2005. PMID: 15889121

3

The role of 3-dimensional mapping biopsy in decision making for treatment of apparent early stage prostate cancer.

Barqawi AB, Rove KO, Gholizadeh S, O'Donnell CI, Koul H, Crawford ED. Barqawi AB, et al. J Urol. 2011 Jul;186(1):80-5. doi: 10.1016/j.juro.2011.03.005. Epub 2011 May 14. J Urol. 2011. PMID: 21571335

4

The role of inflammation and infection in prostate cancer: Importance in prevention, diagnosis and treatment.

Koul HK, Kumar B, Koul S, Deb AA, Hwa JS, Maroni P, van Bokhoven A, Lucia MS, Kim FJ, Meacham RB. Koul HK, et al. Among authors: koul s. Drugs Today (Barc). 2010 Dec;46(12):929-43. doi: 10.1358/dot.2010.46.12.1537942. Drugs Today (Barc). 2010. PMID: 21589950 Review.

5

Molecular aspects of renal cell carcinoma: a review.

Koul H, Huh JS, Rove KO, Crompton L, Koul S, Meacham RB, Kim FJ. Koul H, et al. Am J Cancer Res. 2011;1(2):240-254. Epub 2010 Dec 18. Am J Cancer Res. 2011. PMID: 21969126 Free PMC article.

6

Potentiation of mitomycin C tumoricidal activity for transitional cell carcinoma by histone deacetylase inhibitors in vitro.

Deb AA, Wilson SS, Rove KO, Kumar B, Koul S, Lim DD, Meacham RB, Koul HK. Deb AA, et al. Among authors: koul s, koul hk. J Urol. 2011 Dec;186(6):2426-33. doi: 10.1016/j.juro.2011.07.107. Epub 2011 Oct 21. J Urol. 2011. PMID: 22019171 Retracted.

7

The antioxidant, MnTE-2-PyP, prevents side-effects incurred by prostate cancer irradiation.

Oberley-Deegan RE, Steffan JJ, Rove KO, Pate KM, Weaver MW, Spasojevic I, Frederick B, Raben D, Meacham RB, Crapo JD, Koul HK. Oberley-Deegan RE, et al. Among authors: koul hk. PLoS One. 2012;7(9):e44178. doi: 10.1371/journal.pone.0044178. Epub 2012 Sep 12. PLoS One. 2012. PMID: 22984473 Free PMC article.

8

Clinical-pathologic correlation between transperineal mapping biopsies of the prostate and three-dimensional reconstruction of prostatectomy specimens.

Crawford ED, Rove KO, Barqawi AB, Maroni PD, Werahera PN, Baer CA, Koul HK, Rove CA, Lucia MS, La Rosa FG. Crawford ED, et al. Among authors: koul hk. Prostate. 2013 May;73(7):778-87. doi: 10.1002/pros.22622. Epub 2012 Nov 20. Prostate. 2013. PMID: 23169245 Free PMC article.

9

Regulation of SPDEF expression by DNA methylation in advanced prostate cancer.

Vatanmakanian M, Steffan JJ, Koul S, Ochoa AC, Chaturvedi LS, Koul HK. Vatanmakanian M, et al. Among authors: koul hk. Front Endocrinol (Lausanne). 2023 Oct 11;14:1156120. doi: 10.3389/fendo.2023.1156120. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37900138 Free PMC article.

10

Antiproliferative effects of c-myc antisense oligonucleotide in prostate cancer cells: a novel therapy in prostate cancer.

Balaji KC, Koul H, Mitra S, Maramag C, Reddy P, Menon M, Malhotra RK, Laxmanan S. Balaji KC, et al. Urology. 1997 Dec;50(6):1007-15. doi: 10.1016/s0090-4295(97)00390-7. Urology. 1997. PMID: 9426742

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

83 results

Search Page